{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "CHEK2",
                "DNA Alteration": "c.470T>C",
                "GeneMutation": "p.I157T Nonsense-GOF",
                "VariantAlleleFraction": "18.29%"
            },
            {
                "Gene": "SIX1",
                "DNA Alteration": "c.530A>G",
                "GeneMutation": "p.Q177R Spliceregionvariant-GOF",
                "VariantAlleleFraction": "17.47%"
            },
            {
                "Gene": "CSF1R",
                "DNA Alteration": "c.1085A>G",
                "GeneMutation": "p.H362R Stopgain-LOF",
                "VariantAlleleFraction": "1.77%"
            },
            {
                "Gene": "ZEB2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.H1038R Nonsense-LOF",
                "VariantAlleleFraction": "8.68%"
            },
            {
                "Gene": "CHEK2",
                "DNA Alteration": "c.470T>C",
                "GeneMutation": "p.I157T Stopgain-LOF",
                "VariantAlleleFraction": "6.79%"
            },
            {
                "Gene": "HDAC1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.Y303H Nonsense-LOF",
                "VariantAlleleFraction": "5.96%"
            },
            {
                "Gene": "NRAS",
                "DNA Alteration": "c.37G>A",
                "GeneMutation": "p.G13V Frameshift-LOF",
                "VariantAlleleFraction": "9.25%"
            },
            {
                "Gene": "BLM",
                "DNA Alteration": "c.2207_2212delinsTAGATTC",
                "GeneMutation": "p.Y736fs*4 Stopgain-LOF",
                "VariantAlleleFraction": "8.19%"
            },
            {
                "Gene": "FOXL2",
                "DNA Alteration": "c.402C>G",
                "GeneMutation": "p.C134W Frameshift-GOF",
                "VariantAlleleFraction": "2.98%"
            },
            {
                "Gene": "CALR",
                "DNA Alteration": "c.1154_1155insTTGTC",
                "GeneMutation": "p.L367fs*46 Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "3.66%"
            }
        ],
        "Germline": []
    }
}